Director John C. Dorman bought 100,000 SMRT shares at $1.53 (Aug 18); stock +55.3% in 30 days but -26.2% annual revenue decline
Director Dorman purchased 100,000 shares ($153.5K) at $1.53, increasing his holdings by 35.3% to 383.0K shares. The stock has appreciated 55.3% over 30 days and now trades at $1.50, 23.5% below its 52-week high of $1.96. However, SMRT reported severe headwinds: annual revenue declined 26.2% year-over-year, the company posted a net loss of $10.9M in its most recent quarter, and full-year net income was negative. Additionally, a cluster of 2 other insiders also bought within the past 14 days. Dorman's own cross-ticker track record shows 1 prior buy with a 0% win rate at the 90-day mark (avg 90d return -23.6%), and his sole prior SMRT purchase on 2025-03-10 saw a -23.6% 90-day return, suggesting his timing has been unfavorable in this name. The combination of deteriorating fundamentals, negative prior outcomes in this ticker, and large-share accumulation warrants scrutiny of whether this purchase reflects new information or a contrarian bet into a structurally challenged business.